Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
In Vivo ; 37(1): 329-335, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36593048

RESUMO

BACKGROUND/AIM: Radiotherapy regimens for brain or bone metastases vary substantially. This study compared regimens utilized in Northern Germany and Denmark. PATIENTS AND METHODS: Three centers participating in the Interreg-Project TreaT completed questionnaires regarding preferred radiotherapy regimens for brain or bone metastases. RESULTS: Brain metastases: In poor-prognosis patients, all centers prefer short-course whole-brain irradiation (WBI) for multiple metastases. For oligometastatic disease, two centers prefer WBI, one center fractionated stereotactic radiotherapy (FSRT). For single lesions, all centers use FSRT. In intermediate- or favorable-prognosis patients, longer-course WBI is preferred for multiple lesions, sometimes with simultaneous-integrated boost. For oligo-metastasis, regimens vary. FSRT is preferred for single lesions. Bone metastases: For poor-prognosis patients, single-fraction radiotherapy is used for uncomplicated metastases and short-course radiotherapy for (impending) fractures, large soft-tissue components, and spinal cord compression. Multi-fraction regimens are preferred for intermediate-prognosis and longer-course regimens for favorable-prognosis patients. CONCLUSION: Regimens are relatively similar for bone metastases, single and multiple brain lesions, but vary considerably for few brain metastases. Further cross-border collaboration is required to provide more uniform and optimized treatment standards.


Assuntos
Neoplasias Ósseas , Neoplasias Encefálicas , Radiocirurgia , Humanos , Prognóstico , Neoplasias Encefálicas/secundário , Neoplasias Ósseas/radioterapia , Neoplasias Ósseas/secundário , Encéfalo , Dinamarca
2.
Anticancer Res ; 42(11): 5561-5566, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-36288853

RESUMO

BACKGROUND/AIM: Many cancer patients receive radiotherapy, which may cause distress. This pilot study evaluated distress levels before and after radiotherapy to contribute to the design of a prospective trial. PATIENTS AND METHODS: Two-hundred patients completed distress thermometers before and after radiotherapy. Distress levels ranged from 0 (no distress) to 10 (maximum distress). Five characteristics were retrospectively analyzed regarding changes of distress including age, sex, performance score, tumor type, previous radiotherapy, and treatment intention. Additional analyses were performed for elderly (>65 years) and non-elderly (≤65 years) patients. RESULTS: In all patients and both age groups, median pre-radiotherapy and post-radiotherapy distress levels were 5 (0-10) vs. 4 (0-10) points. Mean changes of distress levels were -0.5 (±2.6) points in all, -0.4 (±2.5) in elderly, and -0.7 (±2.8) in non-elderly patients. Changes were significantly associated with tumor type in all (p=0.049) and elderly (p=0.025) patients. CONCLUSION: Future studies investigating distress levels in patients receiving radiotherapy should consider age and tumor type.


Assuntos
Neoplasias , Angústia Psicológica , Idoso , Humanos , Pessoa de Meia-Idade , Neoplasias/radioterapia , Projetos Piloto , Estudos Prospectivos , Radioterapia/efeitos adversos , Radioterapia/psicologia , Estudos Retrospectivos , Ensaios Clínicos como Assunto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...